The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX

AIMS: To assess whether the use of the femoral or radial approach for percutaneous coronary intervention (PCI) interacted with the efficacy and safety of cangrelor, an intravenous P2Y(12) inhibitor, in CHAMPION PHOENIX. METHODS AND RESULTS: A total of 11 145 patients were randomly assigned in a doub...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutierrez, J. Antonio, Harrington, Robert A., Blankenship, James C., Stone, Gregg W., Steg, Ph. Gabriel, Gibson, C. Michael, Hamm, Christian W., Price, Matthew J., Généreux, Philippe, Prats, Jayne, Deliargyris, Efthymios N., Mahaffey, Kenneth W., White, Harvey D., Bhatt, Deepak L., Bhatt, DL, Stone, GW, Mahaffey, KW, Gibson, CM, Steg, PG, Hamm, CW, Price, MJ, Leonardi, S, Gallup, D, Bramucci, E, Radke, PW, Widimsky, P, Tousek, F, Tauth, J, Spriggs, D, McLaurin, BT, Angiolillo, DJ, Genereux, P, Liu, T, Prats, J, Todd, M, Skerjanec, S, White, HD, Harrington, RA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
FASTTRACK ESC Clinical Trial Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823635/
https://www.ncbi.nlm.nih.gov/pubmed/26400827
http://dx.doi.org/10.1093/eurheartj/ehv498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823635/
https://www.ncbi.nlm.nih.gov/pubmed/26400827
http://dx.doi.org/10.1093/eurheartj/ehv498

Ejemplares similares